Webinar – “Latest advances in the treatment of acute lymphoblastic leukemia (ALL) – What does this mean for patients?” – video recording
On 30 March 2023, CLLAN (CLL Advocates Network) collaborated in the joint initiative with ALAN (Acute Leukemia Advocates Network), CMLAN (CML Advocates Network) and UK charity organisation Leukaemia Care, and hosted fourth webinar in the series.
This webinar brought together international patients with ALL, patient advocates and stakeholders from different countries around the globe. The aim of this educational webinar was to give patients and advocates an overview of how ALL is treated today and the significance of ’hot topics’ and key treatment development advances published and discussed at 2022 international haematology conferences EHA22 and ASH22. What is new and what does this mean for patients?
We were joined by:
Nick York – Patient Advocacy Healthcare Liaison Officer, Leukaemia Care (UK)
Dr Tobias Menne – Consultant Hematologist, Clinical Director for Research, Honorary Senior Lecturer Newcastle University (UK)
Anne – Pierre Pickaert – Patient Advocate, Acute Leukemia Advocates Network (FR)
A big thank you to all patient and advocates who were able to attend live, and to our panellists for their excellent presentation, insight and for sharing their wealth of experience.
We would like to thank the following for their support: